Auto-Owners Insurance 13F: Exits Colgate-Palmolive (CL) Stake
Auto-Owners Insurance has fully exited its investment in Colgate-Palmolive Company, selling off all 5,600 shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Auto-Owners Insurance sold its entire stake of 5,600 shares in Colgate-Palmolive Company ($CL), according to a 13F filing with the SEC dated October 15, 2026.
Since the filing, $CL is up 1.6% to date (from the $92.67 close on Oct 15, 2026).
Find the original: Auto-Owners Insurance 13F filings on SEC EDGAR
Key Points
- Auto-Owners Insurance completely sold out of its Colgate-Palmolive Company position, parting ways with all 5,600 shares.
- Colgate-Palmolive shares recently traded around $93.27, sitting well above their 50-day and 200-day moving averages.
- Wall Street analysts currently hold a buy consensus on the stock with a mean price target of $98.10.
Get $CL trade alerts by text
We text you when insiders, Congress or big funds trade $CL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Colgate-Palmolive Company alert may contain errors. Disclosures
Auto-Owners Insurance has fully closed out its position in Colgate-Palmolive Company (NYSE: CL), according to a Form 13F filing filed with the SEC on October 15, 2026. Institutional 13F filings look backward at holdings from the end of a previous period, so this report captures the fund's move but may not reflect its current holdings today.
Inside Auto-Owners Insurance's Colgate-Palmolive Trade
The fund sold out of its entire stake, getting rid of all 5,600 shares it previously held. Because the fund completely exited the position, this counts as a full sale rather than a partial trim. Institutional filings show what investment managers held at the close of the reporting period, meaning the actual trades could have happened at any point during that quarter.
Other Institutional Activity in Colgate-Palmolive
Other major institutional investors adjusted their own stakes in Colgate-Palmolive around the same reporting window. Blackrock Inc. reduced its holdings by 2,723,979 shares, ending with 69,915,472 shares worth about $6,579,745,112 after a 3.8% cut. Vanguard Capital Management LLC grew its holdings by 26,110 shares, ending with 52,246,333 shares worth about $4,916,902,430 following a 0.1% increase. State Street Corporation trimmed its position by 696,678 shares, finishing with 47,020,966 shares valued at roughly $4,425,143,138 after a 1.5% decrease. Price (T.Rowe) Associates Inc cut its stake by 5,817,998 shares to hold 27,909,525 shares worth about $2,626,565,414 following a 17.2% reduction. Vanguard Portfolio Management LLC added 197,734 shares, wrapping up the period with 24,021,137 shares valued at approximately $2,260,629,217 after a 0.8% increase.
Colgate-Palmolive Company Stock Up 0.5%
Colgate-Palmolive shares recently traded around $93.27. That price sits about 4.6% above its 50-day moving average of $89.13 and roughly 4.9% above its 200-day moving average of $88.92. The stock trades about 6.1% below its 52-week high of $99.33 and roughly 25.1% above its 52-week low of $74.55.
Recent Earnings
Colgate-Palmolive reported trailing-twelve-month revenue of $21,046,990,440 alongside trailing earnings of $2.54 per share. The company posted a net profit margin of 9.7% and a return on equity of 267.4%, with year-over-year revenue growth coming in at 4.9%. Investors can look toward the company's next earnings report scheduled for October 30, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
4 analysts raised price targets.
-
EPS & revenue
EPS met estimates. Revenue missed estimates by 0.9%.
-
Profit surprise
EBITDA missed by 15 percent. Operating income missed by 17 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
4 target raises.
-
Earnings quality
Positive free cash flow.
Earnings Call Summary
Colgate delivered a solid first quarter with accelerating volume growth, especially in emerging markets and the Hill's pet food business, which grew nearly 5 percent. However, North America oral care remains weak and the company faces significant pressure from rising costs in resins, petrochemicals, and oils, which are expected to be up more than 20 percent year over year. Management is confident in its ability to maintain earnings growth through pricing, innovation, and efficiency programs while continuing to invest in brands.
Guidance The company reaffirmed full year earnings growth in the low to mid single digits. They expect gross margins to decline due to about $300 million in additional raw material and logistics costs tied to oil prices around $110 per barrel. They plan to offset inflation through revenue growth management, innovation, and a $200 million to $300 million cost savings program.
Fine but not compelling. Acceptable results that likely do not create a meaningful forward reset.
Dividend
Colgate-Palmolive offers an annual dividend yield of 2.29%, backed by a dividend payout ratio of 82.3%.
Insider Buying and Selling at Colgate-Palmolive Company
Company insiders have also made adjustments to their stock ownership. On May 15, 2026, officer Gregory Malcolm sold 2,300 shares at an average price of $88.44 for a total value of $203,412. Chief Executive Officer Noel R. Wallace disposed of 322,042 shares on August 5, 2026, valued at $29,698,617. Director John T. Cahill sold 4,170 shares on August 6, 2026, at an average price of $93.37 totaling $389,358. Later, on August 24, 2026, officer Panagiotis Tsourapas sold 10,000 shares at an average price of $92.05 worth $920,477. None of these transactions were reported as part of a Rule 10b5-1 trading plan.
Analysts Set New Price Targets
Wall Street firms have kept a steady eye on the stock's valuation. On August 3, 2026, UBS maintained its buy rating while raising its price target from $106.00 to $109.00. On the same day, TD Cowen maintained a hold rating and lifted its target from $85.00 to $90.00. RBC Capital reiterated its outperform rating with a steady target of $104.00 on September 8, 2026. Piper Sandler maintained an overweight rating while lowering its target from $98.00 to $95.00 on September 21, 2026. Wells Fargo maintained an equal-weight rating and cut its price target from $95.00 to $90.00 on October 5, 2026. Across the board, Colgate-Palmolive carries a consensus buy recommendation from 20 analysts with a mean target price of $98.10.
About Colgate-Palmolive Company
Colgate-Palmolive Company manufactures and sells a wide range of consumer goods in the United States and across international markets. The company operates primarily through two main segments focused on oral, personal, and home care items alongside pet nutrition products.
Bottom Line
Auto-Owners Insurance no longer holds any shares of Colgate-Palmolive following this complete exit. Investors will want to check the company's upcoming earnings report on October 30, 2026, to see how the business performs next.
Source: Auto-Owners Insurance's 13F filing on $CL (Oct 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Auto-Owners Insurance 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
